Chemoinformaics analysis of 1-Ethyl-5-methylcyclopentene
| Molecular Weight | 110.2 | nRot | 1 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 5 |
| Exact Molecular Weight | 110.11 | nRing | 1 |
| Solubility: LogS | -3.619 | nHRing | 0 |
| Solubility: LogP | 3.64 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 22.6951 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.455 |
| Synth | 3.564 |
| Natural Product Likeliness | 2.306 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.251 |
| MDCK | 0.0000231 |
| BBB | 0.941 |
| PPB | 0.925623 |
| VDSS | 3.489 |
| FU | 0.0705225 |
| CYP1A2-inh | 0.837 |
| CYP1A2-sub | 0.861 |
| CYP2c19-inh | 0.161 |
| CYP2c19-sub | 0.859 |
| CYP2c9-inh | 0.096 |
| CYP2c9-sub | 0.692 |
| CYP2d6-inh | 0.274 |
| CYP2d6-sub | 0.744 |
| CYP3a4-inh | 0.084 |
| CYP3a4-sub | 0.316 |
| CL | 9.699 |
| T12 | 0.399 |
| hERG | 0.006 |
| Ames | 0.009 |
| ROA | 0.031 |
| SkinSen | 0.1 |
| Carcinogencity | 0.926 |
| EI | 0.947 |
| Respiratory | 0.423 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.955914 |